Ultragenyx drug fails late-stage trial main goal
Ultragenyx Pharmaceutical said its experimental drug for a rare genetic neurodevelopmental disorder did not meet the main goal in a late-stage trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.